This sentiment is furthered by Grassi’s Construction, Architecture & Engineering 2024 Conditions and Outlook Report, when we ...

QIAGEN N.V. today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent infringement, reinforcing its commitment to protecting the scientific advancements behind its ...

AbbVie and Gubra A/S (CPSE:GUBRA), a company specializing in preclinical contract research services and peptide-based drug discovery ...